Povzetek
Introduction: Breast Cancer remains a global health
problem and therefore its early detection and good
diagnostic biomarkers are important for successful
treatment and prevention. Tumour necrosis factor
alpha Single Nucleotide Polymorphisms
(TNFαSNPs) have been implicated in the
presentation of some human cancers. This
preliminary study was carried out to determine for
the first time, the role of TNFα SNPs in breast cancer
amongst Nigerian women and its possible use as risk
assessment tool for breast cancer.
Methods: Participants (200) were recruited from the
University College Hospital, Ibadan for this study.
Genotyping of TNFα and its receptor SNPs from
purified DNA in breast cancer and control samples
were carried out using Polymerase Chain Reaction -
Touch down technique with allele specific primers.
Results: Five alleles showed a significant association
for a reduced risk of breast cancer TNFα 488G
(P=0.0140 OR=0.236, 95%CI= 0.07542 to 0.7391),
TNFα 380G (P=0.0369, OR= 0.5108, 95%CI=
0.5108 to 0.9251), TNFα 308A P=0.0149, OR =
0.3271, 95%CI=0.1373 to 0.7794), and
TNFR1A+IV56+10 -G (P= 0.0024, OR= 0.3535,
95%CI= 0.1851 to 0.6753) TNFα 1032C(P= 0.0158,
OR=2.077 CI=(1.180 to 3.653) with very high
heterozygosity observed among SNPs
Conclusion: Specific genotypic variations in TNFα-
SNPs might be a potential risk factor for breast cancer
among Nigerian population, raising the possibility of
the use of TNFα-SNPs as bio-markers for early risk
indicators for breast cancer in Nigeria.
Literatura
Jedy-Agba E, Curado MP, Ogunbiy O, et al.
Cancer incidence in Nigeria: a report from
population-based cancer registries. Cancer Epid.
; 36(5): 271-278.
Pierce BA. Genetics, A conceptual approach,
eds Freeman W H and Company (New York)
pp627-635.
Demant P. The Genetic Factors in Cancer
Development and their Implications for Cancer
Prevention and Detection. Radiat Res. 2005;
: 462-466.
Xu F, Zhou G, Han S, et al. Association of TNF-
α, TNFRSF1A and TNFRSF1B Gene
Polymorphisms with the Risk of Sporadic Breast
Cancer in Northeast Chinese Han Women. PLoS
One. 2014; 9(7): e101138.
Coleman MP, Quaresma M, Berrino F, et al.
Cancer survival in five continents: a worldwide
population-base study (CONCORD). Lancet
Oncol. 2008; 9(8): 730-756.
Akinde OR, Phillips AA, Oguntunde OA and Afolayan
OM. Cancer Mortality Pattern in Lagos University
Teaching Hospital, Lagos, Nigeria. Journal of
Cancer Epid. 2015; 2015: 1-6.
Weber BL, and Nathanson KL. Low penetrance
genes associated with increased risk for breast
cancer. Europ J of Canc. 2000; 36: 1193-1199.
Fackenthal JD, Sveen L, Gao Q, et al. High
prevalence of BRAC1 and BRCA2 mutations
in unselected Nigerian breast cancer patients.
Internal J of Canc. 2012; 131(5): 1114-23.
Qidwai T and Khan F. Tumour Necrosis Factor
Gene Polymorphism and Disease. Scandinavian
Journal of Immunology. 2011; n/74(6): 522-47.
Jang W H, Yang Y I, Yea S S, et al. The -238
tumor necrosis factor-alpha promoter
polymorphismis associated with decreased
susceptibility to cancers. Cancer Letters. 2001;
: 41-46.
Li H, Zhu H, Liu L, et al. Tumour Necrosis
Factor-α Gene Polymorphism is Associated with
Metastasis in Patients with Triple Negative
Breast Cancer. Scientific Report. 2015; 5: 10244.
Marsh H P, Haldar N A, Bunce M, et al.
Polymorphisms in sstumour necrosis factor
(TNF) are associated with risk of bladder cancer
and grade of tumour at presentation. British
Journal of Cancer. 2003; 89: 1096-1101.
Zuo F, Liang W, Ouyang Y, et al. Association of
TNF-α Gene Promoter Polymorphisms with
Susceptibilty of Cervical Cancer in Southwest
China. Science. 2011; 42(5): 287-290.
Pongsakorn W, Kridsadakorn C, Chumpol N, et
al. WASP: a Web-based Allele-Specific PCR
assay designing tool for detecting SNPs and
mutations. BMC Genomics. 2007; 8:275
doi:10.1186/1471-2164-8-275
Kohaar I, Tiwari P, Kumar R, et al. Association
of single nucleotide polymorphisms (SNPs) in
TNF-LTA locus with breast cancer risk in Indian
population. Breast Cancer Research &
Treatment. 2009; 114(2): 347-355.
Guojiang J, Yan Z, Shuang S and Hui K.
Association between the tumour necrosis factor
alpha gene- 308G>A polymorphism and the risk
of breast cancer: a meta-analysis. Tumour
Biolology. 2014; 35(12): 12091-12098.
Yang Y, Feng R., Bi S, and Xu, Y. TNF-alpha
polymorphisms and breast cancer. Breast Cancer
Research & Treatment. 2011; 129(2): 513-519.
Santovito A, Cervella P, Schleicherova D and
Delpero M. Genotyping for cytokine
polymorphisms in a Northern Ivory Coast
population reveals a high frequency of the
heterozygote genotypes for the TNF-a-308GD
A SNP. International Journal of Immunogenetics,
; 00, 1–5.